Hepatic DDAH1 mitigates hepatic steatosis and insulin resistance in obese mice: Involvement of reduced S100A11 expression

• Asıl Yazarlar: Xiyue Shen (Yazar), Kai Luo (Yazar), Juntao Yuan (Yazar), Junling Gao (Yazar), Bingqing Cui (Yazar), Zhuoran Yu (Yazar), Zhongbing Lu (Yazar)
• Materyal Türü: Kitap
• Baskı/Yayın Bilgisi: Elsevier, 2023-08-01T00:00:00Z.
• Konular: article
• Online Erişim: Connect to this object online.

Dimethylarginine dimethylaminohydrolase 1 (DDAH1) is an important regulator of plasma asymmetric dimethylarginine (ADMA) levels, which are associated with insulin resistance in patients with nonalcoholic fatty liver disease (NAFLD). To elucidate the role of hepatic DDAH1 in the pathogenesis of NAFLD...